These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24505415)

  • 1. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
    PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
    Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
    Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
    Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
    Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City.
    Vanda K; Bobbili N; Matsunaga M; Chen JJ; Salanti A; Leke RFG; Taylor DW
    Front Immunol; 2021; 12():610108. PubMed ID: 33717094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.
    Siriwardhana C; Fang R; Salanti A; Leke RGF; Bobbili N; Taylor DW; Chen JJ
    Malar J; 2017 Sep; 16(1):391. PubMed ID: 28962616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
    Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
    Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
    Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
    J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.
    Fodjo BA; Atemnkeng N; Esemu L; Yuosembom EK; Quakyi IA; Tchinda VH; Smith J; Salanti A; Bigoga J; Taylor DW; Leke RG; Babakhanyan A
    Malar J; 2016 Nov; 15(1):532. PubMed ID: 27814765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax.
    Lopez-Perez M; Larsen MD; Bayarri-Olmos R; Ampomah P; Stevenson L; Arévalo-Herrera M; Herrera S; Hviid L
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29784859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon.
    Lloyd YM; Fang R; Bobbili N; Vanda K; Ngati E; Sanchez-Quintero MJ; Salanti A; Chen JJ; Leke RGF; Taylor DW
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986889
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
    Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
    Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.
    Barfod L; Dalgaard MB; Pleman ST; Ofori MF; Pleass RJ; Hviid L
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12485-90. PubMed ID: 21746929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
    Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
    Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line.
    Yosaatmadja F; Andrews KT; Duffy MF; Brown GV; Beeson JG; Rogerson SJ
    Malar J; 2008 Mar; 7():51. PubMed ID: 18364051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
    Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
    PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.